News

La incorporación del Big Data y la IA al análisis de datos clínicos, de imagen y genómicos está revolucionando la forma en la que se diagnostican, tratan y monitorizan los tumores.

Artificial intelligence (AI) contributes to improved diagnosis, faster image analysis and early detection.

Participating patients will have free access to the genomic study of their tumor, both in the biopsy sample and in blood, to a full-body MRI and to digitization of anatomic pathology images

MD Anderson Cancer Center Foundation Spain is participating in a project, with three other European countries, that will study tumors at a molecular level and seek to expand therapy options in the most advanced stages of endometrial cancer. The study will combine pre-clinical models and artificial intelligence solutions to generate an algorithm to predict the therapeutic response of patients. Endometrial cancer is the most common gynecological tumor in developed countries and the overall survival rate of patients is reduced from 90% to 17% if there is a late diagnosis1